GeneTex
United States (US)

Primary Antibody Diluent

Primary Antibody Diluent. GTX28208

Cat No. GTX28208

Reference 5
Application IHC
See all Antibody diluent products
PRODUCT

Product Description

Primary antibody diluent (with background reducing component)
APPLICATION

Application Note

Preparation of Reagent: Bring the diluent to room temperature and mix thoroughly before use. No further preparation is required. Procedure: 1) Pour the diluent in a clean glass container. 2) Add concentrated primary antibody directly in the diluent and mix thoroughly. 3) Diluted antibody is ready to use now and should be stored at 2-8¼ C for further use.
PROPERTIES

Form

Liquid

Storage

Keep as concentrated solution, aliquot and store at 4ºC.

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
DATA IMAGES
Primary Antibody Diluent. GTX28208

GTX28208 IHC Image


REFERENCE

Application Reference

Liu X et al. Ann Diagn Pathol 2018; 38 : 67-70 FOXP3 and CD25 double staining antibody cocktails identify regulatory T cells in different types of tumor tissues using tissue microarrays.
Hoogsteen IJ et al. Int J Radiat Oncol Biol Phys 2012; 84 (3) : 807-14 Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance.
Nijkamp MM et al. Radiother Oncol 2011; 101 (1) : 165-70 Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
Application : IHC
Hoeben BA et al. J Nucl Med 2010; 51 (7) : 1076-83 PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Troost EG et al. J Nucl Med 2010; 51 (5) : 713-9 Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
Submit a Reference
Package List Price ($)
$ 179